We are live on ! Find out more
MRUS

Merus

Delisted

MRUS was delisted on the 29th of December, 2025.

185 hedge funds and large institutions have $2.98B invested in Merus in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

313% more call options, than puts

Call options by funds: $17.1M | Put options by funds: $4.13M

31% more funds holding in top 10

Funds holding in top 10: 1317 (+4)

14% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 63

1% more capital invested

Capital invested by funds: $2.96B → $2.98B (+$23.5M)

0.27% less ownership

Funds ownership: 102.79%102.53% (-0.27%)

4% less funds holding

Funds holding: 192185 (-7)

23% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 31

Holders
185
Holders Change
-7
Holders Change %
-3.65%
% of All Funds
0%
Holding in Top 10
17
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+30.77%
% of All Funds
0%
New
24
Increased
72
Reduced
63
Closed
31
Calls
$17.1M
Puts
$4.13M
Net Calls
+$12.9M
Net Calls Change
+$11.6M

MRUS Hedge Fund Activity: Q1 2025 in Review

185 institutional investors reported a position in Merus (MRUS) for Q1 2025, worth a combined $2.98B — up 0.79% from $2.96B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of MRUS and 24 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 72 added.

The largest buyer was Paradigm Biocapital Advisors, adding an estimated $73.2M. The largest seller was Boxer Capital Management, cutting an estimated $52.3M.

  • 185 institutional investors held Merus (MRUS) as of Q1 2025, down from 192 in Q4 2024.
  • Funds reported $2.98B of Merus stock for Q1 2025, up 0.79% quarter-over-quarter.
  • 24 funds opened new Merus positions in Q1 2025 and 31 closed out, a net change of -7 holders.
  • The largest Merus buyer in Q1 2025 was Paradigm Biocapital Advisors, an estimated $73.2M added.
  • The largest Merus seller in Q1 2025 was Boxer Capital Management, an estimated $52.3M sold.

Based on aggregated 13F filings for Q1 2025.